Español / English

Index

Authorship

The authors signing the article must have made substantial contributions to various stages of its development, including conceptualization, design, data collection and/or analysis, execution, review, and approval.

Once the article has been accepted by the Editorial Board, no changes to the authors listed will be allowed.

To request a change in authorship, the corresponding author must submit a formal letter addressed to the Editor-in-Chief explaining the reason for the change request, including written consent from all authors as well as consent from the author being added, modified, or removed.

• Requests will be accepted prior to the article’s acceptance.
• Once the article is accepted, only requests for exceptional circumstances will be considered.
• After the article is published, only requests for exceptional circumstances will be considered, and a correction notice will be issued.

 

Originality of the Article

The work must be original and unpublished, not having been previously published (except in the case of abstracts, conference presentations, or academic theses; in such cases, this should be indicated on the first page of the article—see Article Structure section in Instructions for Authors) nor under review by other journals for publication.

Important:

• Any article may be subject to external verification methods to confirm its originality.
• During the evaluation and editing process, the article cannot be submitted to other publications (see Embargo section).
• If the article is rejected, it may then be submitted to other publications.

 

Funding or Financial Support

Authors must indicate if they have received any type of assistance or external funding in:

• The cover letter to the Editor-in-Chief, which should be submitted along with the article through the Submit section.
• The first pages of the article (see the Article Structure section in Instructions for Authors).

 

Copyright Policy

Revista de Neurología operates under a Creative Commons CC-BY-NC-ND license, which allows users, readers, and third parties who access the Revista de Neurología website or platforms (or third parties to whom they transfer the content) to freely download and share the manuscript, with proper recognition of the authorship and citation of the authors as the intellectual creators.

However, users, readers, and third parties accessing the website or platforms of Revista de Neurología (or third parties to whom the content is transferred) may not remix, adapt, or modify it (in whole or in part), nor may they create new works based on the original work. Furthermore, they may not commercialize it or gain any economic benefit from the original work.

 

Author Advocate

Revista de Neurología has an independent professional of recognized prestige who acts on behalf of authors in matters related to ethics and the editorial process. Complaints should be directed to: info@neurologia.com. These complaints should never be sent directly to the person currently holding this role but should go through the publisher and include a reasoned request within the scope of their competence, along with the complainant's contact information.

 

Advertising Policy

Articles published in a regular issue of Revista de Neurología undergo an editorial process to validate publication standards and external peer review, as described in the Publishing Ethic section.

The editorial content in the regular issues of Revista de Neurología is not influenced by financial or commercial interests, nor by specific agreements with clients or sponsors.

Any indication of sponsorship with a potential conflict of interest or commercially sponsored publication may only be published outside the regular issue of Revista de Neurología, where its sponsored nature will be clearly stated.

The publisher reserves the right to reject any article or product in supplement format that contains advertising deemed harmful to the brand or inappropriate for the content of https://www.neurologia.com.

Sponsored products in the scientific or educational fields that may be displayed on https://www.neurologia.com must:

• Not be misleading or biased.
• Include references to support their claims.
• Clearly identify the brand and service.
• Be respectful of personal, racial, ethnic, sexual orientation, and religious aspects.
• Not target specific articles to link them to a brand or product.
• Comply with European advertising legislation standards.

In the case of advertising a pharmaceutical product, the content will be restricted to healthcare professionals through a username and password. Additionally, the advertisement must comply with the aforementioned points and:

• Support all claims with bibliographic references (technical files, studies, etc.).
• Clearly include the full generic name of the active ingredient(s).

 

Post-Publication Quality and Monitoring

Revista de Neurología complies with the protocol regarding the monitoring, amendment, and correction of articles/products in cases where the community has raised and validated serious concerns that justify retraction, including ethical concerns, honest errors, or scientific misconduct.

Any potential issue should be reported to secretaria@neurologia.com, specifying the volume, issue number, and name of the article, along with the observations to be provided.

 

Ethical Responsibilities

All research and related articles must comply with the relevant laws and institutional guidelines. Such as the Biomedical Research Law and International Committee of Medical Journal Editors guidelines.

 

Informed Consent and Privacy

Any study involving subjects (volunteers/patients) requires the approval of an ethics committee and informed consent. Authors must indicate in the article the approval of the ethics committee and the subjects' informed consent.

If the article includes graphic material (images, videos, illustrations, etc.) and/or any type of personal information that could identify a subject, the authors must obtain the appropriate permissions and retain them, without the need to send them to the publisher unless specifically requested.

 

Conflict of Interest

a. Authors

The authors of the article must disclose any financial or personal relationships with organizations or individuals that may exert a direct influence, whether with their own or secondary interests, on the conduct of the research and/or preparation of the article, which could potentially bias the work.

Real or apparent conflicts of interest, whether financial or otherwise, are understood as situations in which a professional judgment or action—meant to be guided by a primary value (such as patient welfare, research integrity, etc.) as defined by professional or ethical standards—might be influenced by another interest (such as economic gain or personal relationships), affecting the actors involved in the research or scientific publication process.

The authors must indicate whether there are conflicts of interest or not in:

• The cover letter to the Editor-in-Chief, which must be submitted along with the article via the Submit section.
• The first pages of the article (see the Article Structure section under Instructions for Authors).

If a conflict exists, they must specify the type of conflict; if not, they should explicitly state it (e.g., “Conflict of Interest: The various individuals involved in the research and/or preparation of the article have no conflicts of interest”).

b. Editorial Board and Reviewers

Only Editorial Board members who have reviewed an article may accept or reject it based on the evaluations performed by experts who act as reviewers. None have financial incentives to accept or reject articles; that is, there are no benefit programs linked to these decisions.

c. Editorial Board

Editorial Board members must declare the conflict of interest upon onboarding.

d. Reviewers

Reviewers must disclose any conflicts of interest through:

• The form designated for reviewer assessments, where they should indicate if a conflict might exist, and, if so, provide details.
• A Conflict of Interest Statement.

 

Studies Involving Humans or Animals

If the research has been conducted with the participation of human subjects, authors must:

• Certify in the article that informed consent has been obtained (see the section on Informed Confidentiality) from all subjects involved, respecting their right to privacy.
• Verify that the study has been conducted in accordance with the ethical code of the World Health Organization (Declaration of Helsinki) on human experimentation.
• Adhere to the recommendations of the International Committee of Medical Journal Editors.

If the research has been conducted with the participation of animals, authors must verify that:

• The ARRIVE guidelines have been followed.
• The study has been conducted in accordance with the UK Animals (Scientific Procedures) Act of 1986.
• The recommendations of EU Directive 2010/63/EU on animal experiments or the National Institutes of Health guide for the care and use of laboratory animals (NIH Publications No. 8023, revised 1978) have been followed.

Note: In both cases, study results are recommended to include the age, race, sex, and ethnic origin of the subjects.

 

Clinical Trials

For the publication of clinical trials, a copy of the approval from health authorities of the countries in which the experimental research is conducted must be submitted.

The Revista de Neurología adheres to the guidelines defined by the 1975 Declaration of Helsinki and its subsequent amendments, as well as paragraph III.J of the Uniform Requirements for Manuscripts Submitted to Biomedical Journals.

The Revista de Neurología will comply with any recommendations or legislation on scientific communication established by the European Union.

 

Confidentiality

The Revista de Neurología guarantees the confidentiality of any work received and of individuals mentioned within it, whether accepted or rejected, throughout all validation and publication processes.

 

Data Availability (Data Sharing)

Revista de Neurología, in its effort to contribute to scientific research, recommends that authors wishing to publish ensure all articles reporting clinical trial results contain a data availability statement; this recommendation extends to all submitted articles of any kind related to research.

Sharing the raw data generated during the course of research, which has been used to extract and validate results, makes science more open and accessible, encouraging these unprocessed data to be reused and applied beyond the purpose for which they were generated, allowing researchers to verify research data or repurpose it for new research.

For further information on data sharing, you may access these two external links to Revista de Neurología:

• Sixto-Costoya A, Aleixandre-Benavent R, Vidal-Infer A, Lucas-Dominguez R, Castello-Cogollos L. Data sharing: What It Is and How Research Data Can Be Shared. Recommendation Manual for Information Managers. Madrid: Sociedad Española de Documentación e Información Científica (SEDIC); 2019. URL: Data Sharing Manual. Last consulted: 27.07.2022.
• Government of Spain. Ministry of Economic Affairs and Digital Transformation. Towards Open Access to Scientific Information in the European Union. Madrid: Government of Spain. Ministry of Economic Affairs and Digital Transformation; 2016. URL: Open Access in EU. Last consulted: 27.07.2022.

The goal is to make shared data findable, accessible, interoperable, and reusable, as promoted by the FAIR principles, recognizing that not all data require the same level of openness or encryption.

 

Open Access

All published articles are uploaded to the website in HTML and PDF formats, available free of charge through www.neurologia.com under a Creative Commons CC-BY-NC-ND license.

This implies that you, as a user or reader of Revista de Neurología, if you wish to use or apply any of the articles published by it:

• Must properly credit the authorship, provide a link to the license, and indicate if any changes were made to the article, provided these do not constitute a derivative work. You may do so in a reasonable manner but not in a way that suggests you are endorsed by the licensor or benefit from the usage.
• May not use the material for commercial purposes.
• If remixing, transforming, or building upon the material, you may not distribute the modified material, nor may you create derivative works from the original article.

However, any user may read, download, copy, distribute, print, search, link to the full text of these articles, crawl them for indexing, transmit them as data to software, or use them for any other lawful, non-commercial purpose without financial, legal, or technical barriers, provided that the article is properly cited.

For derivative (e.g., translations, educational use) or commercial use of the article, contact the publisher, who will review the request and decide whether to grant the necessary authorization.

Any commercial use of any part of the original article must be communicated to Revista de Neurología through secretaria@neurologia.com to obtain explicit permission and pay the associated cost if applicable.

Through open access under a Creative Commons CC-BY-NC-ND license, we aim to provide a sustainable funding model for scientific communications while ensuring the widest and most agile access to research.

 

Embargo

The embargo is the prohibition of disclosing the results of an article under review or accepted for publication to the public until the article has been published due to copyright reasons.

Exceptions may be made at the discretion of the Editor-in-Chief, for example, for works to be presented at annual meetings or in cases where the article describes significant medical advances considered critical. All accredited press representatives who need information to coordinate interviews, press releases, etc., will also be taken into account.

Failure to comply with this regulation may result in the loss of publishing privileges in the journal, withdrawal of the published article, and explicit notification to institutional authorities.